To achieve long term capital growth through the active management of a diversified portfolio invested primarily in European stock markets excluding the United Kingdom.
Name | % Net Assets |
---|---|
Roche Holdings | 4.9% |
Sanofi Aventis | 4.8% |
BASF Namen-AKT | 4.4% |
Nestle SA | 4.2% |
Novartis | 4.0% |
Bayer Motoren WK | 3.1% |
Zurich Financial | 2.8% |
Total | 2.8% |
BNP Paribas | 2.7% |
Deutsche Bank | 2.6% |
Key | % Net Assets |
---|---|
Roche Holdings | 4.9% |
Sanofi Aventis | 4.8% |
BASF Namen-AKT | 4.4% |
Nestle SA | 4.2% |
Other | 81.7% |
Date | 02-Mar-2023 |
---|---|
NAV | 310.72p |
Currency | GBP |
Change | -4.70p |
% | -1.49% |
YTD change | 310.72p |
YTD % | n/a |
Fund Inception | 01/04/1998 |
---|---|
Fund Manager | Quantitative Strategies Team |
TER | 1.68 (18-Nov-2013) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £250 |
Charges | |
---|---|
Initial | 4.00% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research